References
- Australian Bureau of Statistics (“The Causes of Death in Australia 2008”). Leading causes of Death in Australia. [Internet]. 2011 [cited 2012May 7]. Available from http://www.abs.gov.au/ausstats/abs@.nsf/Latestproducts/3303.0Media%20Release12010?opendocument&tabname=Summary&prodno=3303.0&issue=2010&num=&view=
- Thrall, JH. Building Research Programs in Diagnostic Radiology Part III. Clinical and Translational Research. Radiology 2007; 243:5–9.Available from:http://radiology.rsna.org/content/243/1/5.full#sec-3 [Cited 2012 May 7]
- Sarin K. Clinical Trials: Overview and Opportunities [Internet]. Available from http://www.assocham.org/events/recent/event_278/_dr._kumud_sarin.pdf [Cited 2012 May 7]
- U.S. National Institutes of Health. Understanding Clinical Trials. What are the phases of clinical trials? [Internet]. 2007 [updated 2007 Sept 20; cited 2012 May 10] Available from: http://clinicaltrials.gov/ct2/info/understand#Q19
- NHMRC funded research into cancer and other malignant neoplasms 2000 – 2011. [Internet].2012 [page reviewed 2012 Feb 6; cited 2012 Apr 6]. Available from: http://www.nhmrc.gov.au/grants/research-funding-statistics-and-data/funding-datasets/cancer-0
- Information emailed to RANZCR by Sam Thorp | Research Communication and Community Engagement Officer, Cancer Council NSW.
- Delaney G, Jacobs S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment Estimating optimal utilization from a review of evidence-based clinical guidelines. Wiley Online Library. 3 AUG 2005 [cited 2012 May 7]. Available from: http://onlinelibrary.wiley.com/doi/10.1002/cncr.21324/full.
- SBU – The Swedish Council on Technology Assessment in Health Care. Radiotherapy for cancer. Acta Oncologica 1996; 35 (Suppl 6)
- The NIH Common fund office of the strategic coordination. Translational research. [Internet].2011 [updated 2011 Jan 01; cited 2012 Apr 12]. Available from: http://commonfund.nih.gov/clinicalresearch/overview-translational.aspx
- The University of Sydney. Current national competitive grants. [Internet].2010 [updated 2010 Nov 15; cited 2012 Apr 11]. Available from: http://sydney.edu.au/medicine/people/academics/profiles/pkeall.php
- Constantin D E, Fahrig R, Keall P J. A study of the effect of in-line and perpendicular magnetic fields on beam characteristics of electron guns in medical linear accelerators. Med Phys. 2011 Jun; 38 (7): 4174-85
- Thorwarth D, Geets X, Paiusco M. Physical radiotherapy treatment planning based on functional PET/CT data Radiotherapy and Oncology 2010; 96(3): 317-24
- Thorwarth D, Alber M: Implementation of hypoxia imaging into treatment planning and delivery Radiotherapy and Oncology 2010; 97(2): 172-5
- Li XA, Semenenko VA, Alber M et al: The use and QA of biologically related models for treatment planning: Short report of the TG-166 of the therapy physics committee of the AAPM , Med. Phys. 2012;39, 1386
- B Hårdemark, Liander A, Rehbinder H, Loef J, Robinson D. P3IMRT. Biological optimization and EUD. Philips White Paper No. 4535 983 02482 (2004)
- B. Sanchez-Nieto and A. E. Nahum, BIOPLAN: Software for the biological evaluation of radiotherapy treatment plans. Med. Dosim. 2000; 25, 71–76
- Islam M K, Purdie TG, Norrlinger BD, Alasti H et al. Patient dose from kilovoltage cone beam computed tomography imaging in radiation therapy. Med Phys. 2006 Jun ;33 (6):1573-82
- Létourneau D, Wong JW, Oldham M, Gulam M et al. Cone-beam-CT guided radiation therapy: technical implementation. Radiotherapy and Oncology. 2005 Jun; 75 (3): 279-86
- TROG Cancer Research. Open Trials: 10.01 A Multi-centre Feasibility Study of Online Adaptive Image Guided Radiotherapy for Muscle Invasive Bladder Cancer “BOLART” Available from: http://www.trog.com.au/Default.aspx?tabid=70
- Keall P J, Sawant A, Cho B, Ruan D et al. Electromagnetic-Guided Dynamic Multileaf Collimator Tracking Enables Motion Management for Intensity-Modulated Arc Therapy. International Journal of Radiation Oncology, Biology, Physics. 2011 Jan; 79 (1): 312-20
- Arancini WD, Brackenridge SA. Tin foil modified electron radiation of the skin of the nose. The Radiographer 2008; 55 (1): 7–11
- http:/ Cancer Institute NSW. Translational Research Program. [Internet] 2012 [updated 2012 Jan 20; cited 2012 Apr 7]. Available from: http://www.cancerinstitute.org.au/research-grants-and-funding/grants/previous/translational-research
- Written submission from Cancer Australia
- Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson T et al. Number of patients potentially eligible for proton therapy. Acta Oncol. 2005;44:836–49, 200549
- Glimelius B, Montelius A. Proton beam therapy – Do we need the randomized trials and can we do them? Radiotherapy and Oncology. 2007; 83:105–109
- Lodge M, Pijls-Johannesma M, Stirk L, Munro A, De Ruysscher D, Jefferson T, A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer Radiotherapy and Oncology. 2007; 83: 110–122
- Olsen DR, Bruland OS, Frykholm G, Norderhaug IN. Proton therapy – a systematic review of clinical effectiveness. Radiotherapy & Oncology.2007; 83(2):123-132. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17499374
- Submission to the McKeon Review: Clinical cancer research. COSA & CCA Joint submission to the Strategic Review of Health and Medical Research in Australia Clinical Oncological Society of Australia and Cancer Council Australia Clinical Cancer Research. [Internet]. Available from: http://www.mckeonreview.org.au/sub/221_COSA_&_Cancer_Council.pdf